Is telehealth allowed to prescribe Strattera in Texas?

For millions of Americans with ADHD, non-stimulant medications like Strattera (atomoxetine) offer an effective treatment option without the controlled substance restrictions of stimulants. But can you get these medications through telehealth? This comprehensive guide explains the current laws and regulations for telehealth prescribing of ADHD non-stimulants as of December 2025.

Can You Get Non-Stimulant ADHD Medication Through Telehealth?

Yes, you can. Non-stimulant ADHD medications like Strattera can be prescribed via telehealth in all states. Since these medications are not controlled substances, they aren’t subject to the DEA’s special in-person exam requirements that sometimes apply to stimulants like Adderall.

‘Non-stimulant medications provide a valuable option for ADHD treatment, especially for patients who can’t tolerate stimulants or have concerns about controlled substances,’ explains Dr. Sarah Chen, Chief Medical Officer at Klarity Health. ‘And the good news is that these medications can be legally prescribed through telehealth without many of the special restrictions that apply to controlled medications.’

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding Medication Classifications: Why It Matters for Telehealth

To understand the telehealth regulations, it’s important to know how medications are classified:

Strattera works differently than stimulants. Instead of increasing dopamine like Adderall, it affects norepinephrine levels in the brain. Because it’s not habit-forming, the DEA doesn’t classify it as a controlled substance, making it easier to prescribe via telehealth.

Current Federal Regulations (As of December 2025)

The DEA’s current telehealth rules for controlled substances are operating under a temporary extension that expires December 31, 2025. This is the ‘Third Extension’ of COVID-era flexibilities, which allows telehealth prescribing of controlled substances without an in-person exam.

However, these special DEA rules don’t impact non-stimulant medications like Strattera at all. Non-stimulants have always been prescribable via telehealth, even before the pandemic. They’ll remain accessible via telehealth regardless of what happens with the DEA rules for controlled substances in 2026.

State-by-State Telehealth Rules for ADHD Non-Stimulants

While federal law allows telehealth prescribing of non-stimulants nationwide, some states have their own regulations. Here’s what you need to know about key states:

California

• Can prescribe non-stimulants via telehealth? Yes
• In-person exam required? No
• Who can prescribe? MDs, DOs, NPs (independent after experience requirements), and PAs (with collaboration)
• 2025 update: California remains telehealth-friendly for non-stimulant ADHD medications

New York

• Can prescribe non-stimulants via telehealth? Yes
• In-person exam required? No (only required for controlled substances)
• Who can prescribe? MDs, DOs, and NPs (independent after 3,600 hours), PAs (with collaboration)
• 2025 update: NY implemented strict in-person requirements for controlled substances, but these don’t apply to Strattera

Florida

• Can prescribe non-stimulants via telehealth? Yes
• In-person exam required? No
• Who can prescribe? MDs, DOs, and NPs/PAs (with collaboration)
• 2025 update: Florida allows telehealth prescribing of non-controlled medications without special restrictions

Texas

• Can prescribe non-stimulants via telehealth? Yes
• In-person exam required? No
• Who can prescribe? MDs, DOs, and NPs/PAs (with physician delegation)
• 2025 update: Texas remains telehealth-friendly for non-stimulant ADHD medications

Alabama

• Can prescribe non-stimulants via telehealth? Yes
• In-person exam required? Generally once per year for ongoing telehealth care, but mental health services (including ADHD) are exempt from this requirement
• Who can prescribe? MDs, DOs, and NPs/PAs (with collaboration)
• 2025 update: Alabama maintains stricter telehealth rules than most states, but mental health exemptions help ADHD patients

In all states, licensed physicians can prescribe non-stimulant ADHD medications via telehealth. The main state-to-state differences involve who else can prescribe (NPs/PAs) and any special documentation requirements.

What to Expect from a Legitimate Telehealth ADHD Evaluation

A proper telehealth evaluation for ADHD should be comprehensive, whether you’re seeking stimulants or non-stimulants. Here’s what to expect:

1. Thorough intake process – Questionnaires about symptoms, medical history, and possibly childhood records
2. Video consultation – A face-to-face virtual appointment with a licensed provider
3. Diagnostic assessment – Questions based on DSM-5 criteria for ADHD
4. Discussion of treatment options – Including medications and non-medication approaches
5. Prescription if appropriate – Sent electronically to your pharmacy
6. Follow-up appointments – To monitor effectiveness and any side effects

‘At Klarity Health, we follow the same diagnostic standards whether a patient is seen virtually or in-person,’ notes Dr. Chen. ‘Our telehealth ADHD evaluations include comprehensive assessments using validated tools, just as you’d expect in a traditional office setting.’

Common Questions About Telehealth ADHD Non-Stimulant Treatment

Is Strattera as effective as stimulants for ADHD?

Strattera can be very effective, though it works differently than stimulants. While stimulants provide same-day effects, Strattera typically takes 4-6 weeks to reach full effectiveness. Some patients find it works better for them, especially if they experience anxiety alongside ADHD or have had side effects from stimulants.

Will insurance cover telehealth ADHD treatment?

Most insurance plans now cover telehealth for mental health services, including ADHD treatment. Coverage for the medication itself depends on your specific pharmacy benefits. Klarity Health works with most major insurance plans and also offers transparent cash pricing for those without coverage.

How do telehealth providers verify my identity?

Legitimate telehealth providers require identity verification, typically through government ID verification and sometimes video confirmation during your appointment. This ensures proper care and compliance with prescribing laws.

Will pharmacies fill prescriptions from telehealth providers?

Yes, pharmacies regularly fill prescriptions from licensed telehealth providers. Non-stimulant prescriptions like Strattera rarely face scrutiny since they’re not controlled substances. Electronic prescriptions are standard practice and don’t indicate whether the prescription came from a telehealth or in-person visit.

What happens if I move to a different state?

You’ll need to inform your provider. Since medical licenses are state-specific, you may need to switch to a provider licensed in your new state. Platforms like Klarity Health can often facilitate this transition within their network of providers.

Red Flags: How to Identify Illegitimate Telehealth ADHD Services

Not all telehealth providers are created equal. Avoid services that:

• Guarantee a prescription before evaluation
• Skip video appointments (text-only evaluations)
• Don’t verify your identity
• Have extremely brief consultations (less than 20 minutes)
• Offer to ship medications directly from overseas
• Don’t require follow-up appointments

Legitimate providers like Klarity Health conduct thorough evaluations, require video visits, verify identity, and schedule appropriate follow-ups to ensure effective treatment.

Tips for Telehealth ADHD Treatment Success

1. Be honest and thorough during your evaluation – The quality of your care depends on the information you provide
2. Attend follow-up appointments – These are crucial for monitoring treatment effectiveness
3. Keep track of side effects – Document any issues to discuss with your provider
4. Use medications exactly as prescribed – Even

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment